About Aatru Medical

Aatru Medical has developed NPSIMS, a patented negative pressure wound therapy device that utilizes a solid-state oxygen management system to deliver consistent negative pressure for up to seven days. This technology effectively reduces surgical site infections and complications associated with surgical incisions, enhancing patient outcomes and streamlining clinical workflows.

```xml <problem> Surgical site infections and complications, such as dehiscence, can negatively impact patient outcomes and increase healthcare costs. Traditional methods of surgical incision management may not adequately address factors that impede wound healing, particularly in patients with comorbidities. </problem> <solution> Aatru Medical's NPSIMS (Negative Pressure Surgical Incision Management System) offers an innovative approach to surgical incision management by utilizing a solid-state oxygen management system to deliver consistent negative pressure wound therapy (NPWT) for up to seven days. This patented technology creates a closed environment that removes exudate, reduces edema and hematoma/seroma formation, and immobilizes wound edges, promoting faster and more effective healing. The device's unique mechanism of action, based on the Ideal Gas Law, requires no moving parts, batteries, or manual pressure adjustments, simplifying application and minimizing the risk of over-pressure. NPSIMS is designed for ease of use, patient comfort, and cost-effectiveness, offering a comprehensive solution for surgical incision management. </solution> <features> - Solid-state oxygen management system maintains consistent negative pressure (-80 mmHg +/- 20 mmHg) for up to 7 days. - Patented mechanism of action with no moving parts, batteries, or pressure settings. - Unique silicone gasket ensures a reliable vacuum seal. - Defaults to an advanced wound dressing if pressure is lost. - Super-absorbent pad locks in fluid and allows visual assessment of exudate. - Simple visual indicators guide and alert on performance. - Lightweight, compact, and contoured design for patient comfort and discreet wear. - Pre-assembled for quick and easy application. </features> <target_audience> The primary target audience includes surgeons across various specialties (abdominal, cardiothoracic, colorectal, obstetric, orthopedic, pediatric, plastic/breast, trauma, vascular) and clinicians managing surgical incisions, particularly in patients with risk factors such as high BMI, diabetes, cardiovascular disease, or compromised immune systems. </target_audience> ```

What does Aatru Medical do?

Where is Aatru Medical located?

Aatru Medical is based in Cleveland, United States.

When was Aatru Medical founded?

Aatru Medical was founded in 2017.

How much funding has Aatru Medical raised?

Aatru Medical has raised 3540000.

Location

Cleveland, United States

Founded

2017

Funding

3540000

Employees

6 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Aatru Medical

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

aatru.com 200+

Crunchbase

Founded 2017 – Cleveland, United States

Funding

Estimated Funding

$3M+

Team (5+)

No team information available.

Company Description

Problem

Surgical site infections and complications, such as dehiscence, can negatively impact patient outcomes and increase healthcare costs. Traditional methods of surgical incision management may not adequately address factors that impede wound healing, particularly in patients with comorbidities.

Solution

Aatru Medical's NPSIMS (Negative Pressure Surgical Incision Management System) offers an innovative approach to surgical incision management by utilizing a solid-state oxygen management system to deliver consistent negative pressure wound therapy (NPWT) for up to seven days. This patented technology creates a closed environment that removes exudate, reduces edema and hematoma/seroma formation, and immobilizes wound edges, promoting faster and more effective healing. The device's unique mechanism of action, based on the Ideal Gas Law, requires no moving parts, batteries, or manual pressure adjustments, simplifying application and minimizing the risk of over-pressure. NPSIMS is designed for ease of use, patient comfort, and cost-effectiveness, offering a comprehensive solution for surgical incision management.

Features

Solid-state oxygen management system maintains consistent negative pressure (-80 mmHg +/- 20 mmHg) for up to 7 days.

Patented mechanism of action with no moving parts, batteries, or pressure settings.

Unique silicone gasket ensures a reliable vacuum seal.

Defaults to an advanced wound dressing if pressure is lost.

Super-absorbent pad locks in fluid and allows visual assessment of exudate.

Simple visual indicators guide and alert on performance.

Lightweight, compact, and contoured design for patient comfort and discreet wear.

Pre-assembled for quick and easy application.

Target Audience

The primary target audience includes surgeons across various specialties (abdominal, cardiothoracic, colorectal, obstetric, orthopedic, pediatric, plastic/breast, trauma, vascular) and clinicians managing surgical incisions, particularly in patients with risk factors such as high BMI, diabetes, cardiovascular disease, or compromised immune systems.